Development of a poegma-aptamer rapid onset anticoagulant that eliminates antigenicity to anti-peg antibodies
Ended Project Grant Awarded Last action
- Award ID
- R41HL139234
- Recipient
-
Gateway Bio Inc. UEI MLZ9QD9YXCN7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $277,130
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Durham, NC 27712, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $277,130 |
Quick answers
Who received award R41HL139234?
R41HL139234 was awarded to Gateway Bio Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 15, 2017.
How much is award R41HL139234 worth?
$277,130 has been obligated on R41HL139234.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award